Status
Conditions
Treatments
About
This study is a Post-Marketing Surveillance study in Korea to evaluate the safety and efficacy of botulinum toxin Type A to treat urinary incontinence in patients with neurogenic detrusor overactivity (NDO) or overactive bladder (OAB) not adequately controlled by anticholinergic drugs.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
-Patients with urinary incontinence due to NDO or OAB treated with BOTOX® as per local standard of care in clinical practice.
Exclusion criteria
-None.
523 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal